February 28, 2020 / 2:26 PM / a month ago

BRIEF-RhoVac Gets FDA Approval In US For Start Of Its Phase IIb Clinical Trial

Feb 28 (Reuters) - RhoVac AB:

* RECEIVES FDA APPROVAL IN US FOR START OF ITS PHASE IIB CLINICAL TRIAL

* RESULTS REPORT ON ACTIVE TREATMENT PART OF STUDY IS EXPECTED IN H2 2021 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below